# Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments

> clinical trial · VERIFIED · 2026-09-03

Status: NOT_YET_RECRUITING · Sponsor: Instituto de Investigación Biomédica de Salamanca · Condition: Dry Eye Disease (DED)

- Company: Instituto de Investigación Biomédica de Salamanca
- Sector: biotech
- Primary source: https://clinicaltrials.gov/study/NCT06905834

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.